CanVIG-UK 2022, ' Reclassification of clinically-detected sequence variants : Framework for genetic clinicians and clinical scientists by CanVIG-UK (Cancer Variant Interpretation Group UK) ', Genetics in medicine : official journal of the American College of Medical Genetics, vol. 24, no. 9, pp. 1867-1877 . https://doi.org/10.1016/j.gim.2022.05.002
Loong, L, Cubuk, C, Choi, S, Allen, S, Torr, B, Garrett, A, Loveday, C, Durkie, M, Callaway, A, Burghel, GJ, Drummond, J, Robinson, R, Berry, IR, Wallace, A & CanVIG-UK 2021, ' Quantifying prediction of pathogenicity for within-codon concordance (PM5) using 7541 functional classifications of BRCA1 and MSH2 missense variants. ', Genetics in medicine : official journal of the American College of Medical Genetics, vol. 24, no. 3, pp. 552-563 . https://doi.org/10.1016/j.gim.2021.11.011
Journal of Medical Genetics Callaway, A, Durkie, M, Cubuk, C, Alikian, M, Burghel, GJ, Izatt, L, Talukdar, S, Side, L, Cranston, T, Palmer-Smith, S, Baralle, D & CanVIG-UK 2020, ' Cancer Variant Interpretation Group UK (CanVIG-UK): an exemplar national subspecialty multidisciplinary network. ', Journal of Medical Genetics . https://doi.org/10.1136/jmedgenet-2019-106759
Durkie, M, Callaway, A, Burghel, GJ, Drummond, J, Torr, B, Cubuk, C, Berry, IR, Wallace, AJ, Ellard, S, Eccles, DM, Tischkowitz, M & CanVIG-UK 2020, ' Combining evidence for and against pathogenicity for variants in cancer susceptibility genes: CanVIG-UK consensus recommendations. ', Journal of Medical Genetics . https://doi.org/10.1136/jmedgenet-2020-107248